Most recent PSA 8/2016 was 5.5 ng/mL. Prior PSA from 9/2015 was 5.1 ng/mL. Prolaris score = 3.4. He currently has no urinary symptoms. Prostate biopsy from 2010 was benign. PELVIS:PROSTATE:Prostate Size: 4.9 x 2.6 x 3.7 cmPeripheral Zone: Left peripheral zone T2 low (series 601 image 88) and ADC low (series 708 image 324) focus with early arterial enhancement.Central Gland: Right prostate base at the junction of the transition zone, peripheral zone, and central zone with T2 low (series 601 image 97) and ADC low (series 708 image 364) focus. This may represent extension of hyperplastic nodule from transition zone, but cannot exclude malignancy.Seminal Vesicles: No evidence of seminal vesicle invasion.Extracapsular Extension: No evidence of extracapsular extension.BLADDER: No significant abnormality noted.LYMPH NODES: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
1.Left peripheral zone T2 low and ADC low focus with early arterial enhancement, PIRADS 4.2.Right prostate base T2 low and ADC low focus, PIRADS 3.PI-RADS™ v2 Assessment Categories:PIRADS 1 – Very low (clinically significant cancer is highly unlikely to be present) PIRADS 2 – Low (clinically significant cancer is unlikely to be present)PIRADS 3 – Intermediate (the presence of clinically significant cancer is equivocal)PIRADS 4 – High (clinically significant cancer is likely to be present) PIRADS 5 – Very high (clinically significant cancer is highly likely to be present)https://www.acr.org/~/media/ACR/Documents/PDF/QualitySafety/Resources/PIRADS/PIRADS%20V2.pdf